Logo image
Respiratory fluoroquinolone use and influenza
Journal article   Peer reviewed

Respiratory fluoroquinolone use and influenza

Philip M Polgreen, Ming Yang, Ramanan Laxminarayan and Joseph E Cavanaugh
Infection control and hospital epidemiology, Vol.32(7), pp.706-709
07/2011
DOI: 10.1086/660859
PMCID: PMC3258490
PMID: 21666403
url
https://www.ncbi.nlm.nih.gov/pmc/articles/3258490View
Open Access

Abstract

We show that respiratory fluoroquinolone use is extremely seasonal and that fluoroquinolone use is strongly associated with influenza. In our time series model, instantaneous influenza activity was a significant predictor of use (P < .0001). Also, we estimated that reducing influenza activity by 20% would reduce prescriptions by 8%.
Anti-Bacterial Agents - therapeutic use Regression Analysis United States - epidemiology Inappropriate Prescribing Humans Adult Fluoroquinolones - therapeutic use Influenza, Human - epidemiology Respiratory Tract Infections - drug therapy Respiratory Tract Infections - epidemiology Seasons Drug Utilization - statistics & numerical data

Details

Metrics

Logo image